Filter your results
- 4
- 1
- 2
- 2
- 1
- 5
- 1
- 2
- 1
- 2
- 5
- 4
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 5
- 4
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
New pi3k/akt/mtor inhibitors and pharmaceutical uses thereofFrance, Patent n° : WO 2015044229 / EP 2853530. 2015
Patents
hal-01139914v1
|
|||
|
The cleaved FAS ligand activates the Na+/H+ exchanger NHE1 through Akt/ROCK1 to stimulate cell motilityScientific Reports, 2016, 6 (1), pp.28008. ⟨10.1038/srep28008⟩
Journal articles
hal-01334067v1
|
||
CD95-Mediated Proton RegulationCD95: Methods and Protocols, Methods in Molecular Biology, vol. 1557,, 6 (1), pp.95-102, 2017, ⟨10.1007/978-1-4939-6780-3_9⟩
Book sections
hal-02570274v1
|
|||
A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer CellsJournal of Medicinal Chemistry, 2015, 58 (16), pp.6559-6573. ⟨10.1021/acs.jmedchem.5b00991⟩
Journal articles
hal-01187307v1
|
|||
Study of the CD95-Mediated Non-apoptotic Signaling Pathway: PI3KCD95: Methods and Protocols, 1557, pp.103-110, 2017, Methods in Molecular Biology, ⟨10.1007/978-1-4939-6780-3_10⟩
Book sections
hal-01447230v1
|